22-35330371-A-G

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4BP6BS2

The NM_005488.3(TOM1):​c.790A>G​(p.Met264Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00108 in 1,613,028 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00080 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 5 hom. )

Consequence

TOM1
NM_005488.3 missense

Scores

8
6
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 9.27

Publications

8 publications found
Variant links:
Genes affected
TOM1 (HGNC:11982): (target of myb1 membrane trafficking protein) This gene was identified as a target of the v-myb oncogene. The encoded protein shares its N-terminal domain in common with proteins associated with vesicular trafficking at the endosome. It is recruited to the endosomes by its interaction with endofin. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
TOM1 Gene-Disease associations (from GenCC):
  • immune system disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • immunodeficiency 85 and autoimmunity
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.35953468).
BP6
Variant 22-35330371-A-G is Benign according to our data. Variant chr22-35330371-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 2342348.
BS2
High AC in GnomAd4 at 122 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TOM1NM_005488.3 linkc.790A>G p.Met264Val missense_variant Exon 8 of 15 ENST00000449058.7 NP_005479.1 O60784-1B3KUF5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TOM1ENST00000449058.7 linkc.790A>G p.Met264Val missense_variant Exon 8 of 15 1 NM_005488.3 ENSP00000394466.2 O60784-1

Frequencies

GnomAD3 genomes
AF:
0.000802
AC:
122
AN:
152052
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00165
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000520
AC:
130
AN:
250074
AF XY:
0.000540
show subpopulations
Gnomad AFR exome
AF:
0.000247
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000467
Gnomad NFE exome
AF:
0.000982
Gnomad OTH exome
AF:
0.00115
GnomAD4 exome
AF:
0.00110
AC:
1614
AN:
1460976
Hom.:
5
Cov.:
32
AF XY:
0.00109
AC XY:
791
AN XY:
726820
show subpopulations
African (AFR)
AF:
0.000210
AC:
7
AN:
33406
American (AMR)
AF:
0.000224
AC:
10
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26104
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39628
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86220
European-Finnish (FIN)
AF:
0.0000377
AC:
2
AN:
53104
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00137
AC:
1518
AN:
1111696
Other (OTH)
AF:
0.00128
AC:
77
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
81
162
243
324
405
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000802
AC:
122
AN:
152052
Hom.:
0
Cov.:
32
AF XY:
0.000633
AC XY:
47
AN XY:
74248
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41396
American (AMR)
AF:
0.000262
AC:
4
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10568
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00165
AC:
112
AN:
68032
Other (OTH)
AF:
0.000478
AC:
1
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00103
Hom.:
0
Bravo
AF:
0.000782
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.000494
AC:
60
EpiCase
AF:
0.000872
EpiControl
AF:
0.00107

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 04, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.790A>G (p.M264V) alteration is located in exon 8 (coding exon 8) of the TOM1 gene. This alteration results from a A to G substitution at nucleotide position 790, causing the methionine (M) at amino acid position 264 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Benign:1
Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TOM1: BS1 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.61
BayesDel_addAF
Benign
-0.040
T
BayesDel_noAF
Pathogenic
0.16
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.078
.;T;.;.;T
Eigen
Pathogenic
0.88
Eigen_PC
Pathogenic
0.82
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.99
D;D;D;D;D
M_CAP
Benign
0.055
D
MetaRNN
Benign
0.36
T;T;T;T;T
MetaSVM
Uncertain
-0.19
T
MutationAssessor
Pathogenic
2.9
.;.;M;.;M
PhyloP100
9.3
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-3.5
D;D;D;D;D
REVEL
Uncertain
0.55
Sift
Pathogenic
0.0
D;D;D;D;D
Sift4G
Uncertain
0.0020
D;D;D;D;D
Polyphen
1.0, 0.98, 1.0
.;.;D;D;D
Vest4
0.88
MVP
0.83
MPC
0.92
ClinPred
0.12
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.94
gMVP
0.67
Mutation Taster
=35/65
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34371697; hg19: chr22-35726364; COSMIC: COSV65899018; COSMIC: COSV65899018; API